-
Novartis, Mundipharma ink partnership to enhance access to three Asian countries to established medicine brands for glaucoma and external eye diseases
prnasia
August 06, 2019
International healthcare organizations, Novartis and Mundipharma, have signed a landmark agreement for the marketing, sales and distribution rights of Novartis medicines in
-
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
prnasia
August 06, 2019
Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today announced that ...
-
MediBeacon enters into $30 M partnership with Huadong Medicine
biospectrumasia
August 01, 2019
MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon's entire portfolio of assets in Greater China
-
Alvotech in partnership with Cipla Gulf
expresspharma
July 30, 2019
Biopharmaceutical company Alvotech and Cipla Gulf have entered into an exclusive partnership for the commercialisation of AVT02, an adalimumab biosimilar, in select emerging markets.
-
Just Biotherapeutics and Teva Form Biologics Partnership
contractpharma
July 04, 2019
Will collaborate on the design and development of a high productivity biomanufacturing process.
-
Enable Injections Enters into Partnership with Sanofi
contractpharma
June 12, 2019
Enable's enFuse delivers high-volume therapeutics outside of the clinical setting.
-
Connect 2 Cleanrooms and Elis Cleanroom announce partnership
europeanpharmaceuticalreview
May 24, 2019
Connect 2 Cleanrooms and Elis Cleanroom announce partnership.
-
Micro-Sphere partnership to further support the commercial needs of its customers
cphi-online
May 05, 2019
Customers will receive comprehensive support particularly at the critical phases of industrial scale-up, technology transfer and process validation.
-
BioInvent receives €0.75 M under Mitsubishi Tanabe Pharma partnership
biospectrumasia
April 28, 2019
The license agreement with Mitsubishi Tanabe Pharma covers the development of antibodies from the n-CoDeR antibody library.
-
CPhI NA Partners with iBIO
contractpharma
April 24, 2019
CPhI North America has formed a new partnership with Illinois Biotechnology Innovation Organization (iBIO). Through the partnership, CPhI North America will donate $10,000 to the iBIO EDUCATE Center